weight gain on glp 1 across pregnancy by glucagon-like peptide-1 (GLP-1) agonist The percentage of U.S. adults
Description
several large ones show no increase

Let's break down exactly what the data shows, where the side effect risks shift, and who should actually consider making the move

503A designated This ensures that all compounding of each medication is performed by a licensed pharmacist in a state licensed pharmacy or a Federal facility
Muscle Loss Risk Increases (Major Concern) GLP-1 users already risk: low protein intake low calorie intake rapid weight loss lean tissue loss Add nightly alcohol and you get: impaired muscle protein synthesis lower testosterone (men) reduced growth hormone increased cortisol reduced recovery Result: More muscle loss Less fat loss Softer look Slower metabolism This is one of the biggest physiological downsides
There is no required waiting period between stopping Trulicity and starting Mounjaro

ClinicalTrials.gov Identifier: NCT04537923
